2026. The oncogenic implications of metabolic dysfunction-associated steatotic liver disease. Journal of Renal and Hepatic Disorders. 10, 1 (Jun. 2026), 14–23. DOI:https://doi.org/10.63268/jrenhp.v10i1.252.